Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-05

FDA Approved: BETAXOLOL HYDROCHLORIDE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for Betaxolol hydrochloride submitted by Sandoz Inc, updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betaxolol hydrochloride (betaxolol hydrochloride)

Snippet

SUPPL AP for BETAXOLOL HYDROCHLORIDE (BETAXOLOL HYDROCHLORIDE)